First Advantage FA 深 滬
等待開盤 07-28 09:30:00 美东时间
20.01
+0.370
+1.88%
華盛通- 最 高20.31
- 今 開19.78
- 成交量 176.07万股
- 最 低 19.66
- 昨 收 19.64
- 總市值 34.32亿
- 52周最高 22.78
- 市盈率 靜 --
- 換手率 1.03%
- 52周最低 8.82
- 委 比 47.97%
- 總股本 1.72亿
- 歷史最高 23.23
- 量 比 0.86
- 振 幅 3.31%
- 歷史最低 8.57
- 每 手 1
- 風險率 2.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多First Advantage Named to TIME’s 2026 List of America’s Best Companies
First Advantage Corporation has been named #1 in Background Screening and Identity Verification on TIME’s 2026 list of America’s Best Companies, ranking among the top 25 in Professional Services. The recognition, in collaboration with Statista, evaluates Employee Satisfaction, Financial Performance, and Sustainability Transparency. First Advantage also ranks in the top three Professional Services companies by financial performance. CEO Scott Stap...
07-21 20:05
First Advantage to Release Second Quarter 2026 Financial Results and Hold Investor Conference Call on August 6, 2026
First Advantage Corporation (NASDAQ: FA), a global software and data company, will release its Q2 2026 financial results on August 6, 2026, followed by an earnings conference call at 8:30 a.m. ET. Participants can join via phone or webcast at investors.fadv.com. A replay will be available post-call. First Advantage provides identity solutions, background screening, and risk monitoring, serving over 80,000 global customers.
07-16 11:00
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Barclays Maintains Overweight on First Advantage, Raises Price Target to $20
Barclays analyst Manav Patnaik maintains First Advantage (NASDAQ:FA) with a Overweight and raises the price target from $15 to $20.
05-08 22:55
First Advantage shares are trading higher after the company reported better-than-expected Q1 financial results.
First Advantage shares are trading higher after the company reported better-tha...
05-07 20:43
First Advantage Affirms FY2026 Adj EPS Guidance of $1.15-$1.25 vs $1.20 Est; Affirms FY2026 Sales Guidance of $1.625B-$1.700B vs $1.655B Est
First Advantage (NASDAQ:FA) affirms FY2026 Adj EPS guidance from $1.15-$1.25 to $1.15-$1.25 vs $1.20 analyst estimate. Affirms FY2026 sales outlook from $1.625 billion-$1.700 billion to $1.625 billion-$1.700 billion vs
05-07 18:04
First Advantage Q1 Adj. EPS $0.26 Beats $0.21 Estimate, Sales $385.200M Beat $372.602M Estimate
First Advantage (NASDAQ:FA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.21 by 23.81 percent. This is a 52.94 percent increase over earnings of $0.17 per share from the
05-07 18:04
AI ETFs Hit 52-Week Highs—But The Math Just Doesn't Add Up
AI ETFs hit 52-week highs as investors piled into the AI trade, but weak corporate ROI visibility raises questions about the sustainability of the rally.
05-06 03:13
Jamie Dimon Sounds The Alarm On Critical Mineral Vulnerability
JPMorgan expands $1.5T security initiative to Europe as Jamie Dimon warns fragile critical mineral supply chains threaten global stability.
04-21 18:32
